These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29279247)

  • 1. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
    Ryan AT; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Res; 2018 Jul; 197():522-530. PubMed ID: 29279247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.
    Velthorst E; Meyer EC; Giuliano AJ; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Seidman LJ
    Schizophr Res; 2019 Feb; 204():311-319. PubMed ID: 30078717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.
    Zaks N; Velikonja T; Parvaz MA; Zinberg J; Done M; Mathalon DH; Addington J; Cadenhead K; Cannon T; Cornblatt B; McGlashan T; Perkins D; Stone WS; Tsuang M; Walker E; Woods SW; Keshavan MS; Buysse DJ; Velthorst E; Bearden CE
    Schizophr Bull; 2022 Jan; 48(1):111-121. PubMed ID: 34536012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.
    Gupta T; Cowan HR; Strauss GP; Walker EF; Mittal VA
    Schizophr Bull; 2021 Jan; 47(1):54-63. PubMed ID: 32955097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort.
    Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH
    Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
    Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator.
    Worthington MA; Miklowitz DJ; O'Brien M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Early Interv Psychiatry; 2021 Feb; 15(1):96-103. PubMed ID: 31943807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
    Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW
    Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
    Healey KM; Penn DL; Perkins D; Woods SW; Keefe RSE; Addington J
    Schizophr Bull; 2018 Feb; 44(2):286-296. PubMed ID: 29036587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample.
    Osborne KJ; Mittal VA
    Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description.
    Addington J; Liu L; Brummitt K; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Schizophr Res; 2022 May; 243():262-267. PubMed ID: 32317224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.
    Meyer EC; Carrión RE; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Heinssen R; Seidman LJ;
    Schizophr Bull; 2014 Nov; 40(6):1452-61. PubMed ID: 24550526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.